Gil D - Search Results

1

Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors.

Hsia E, Tian M, Gil D. Hsia E, et al. Among authors: gil d. Exp Dermatol. 2018 Jul;27(7):763-768. doi: 10.1111/exd.13557. Epub 2018 May 10. Exp Dermatol. 2018. PMID: 29637626

2

A peripheral adrenoceptor-mediated sympathetic mechanism can transform stress-induced analgesia into hyperalgesia.

Donello JE, Guan Y, Tian M, Cheevers CV, Alcantara M, Cabrera S, Raja SN, Gil DW. Donello JE, et al. Anesthesiology. 2011 Jun;114(6):1403-16. doi: 10.1097/ALN.0b013e31821c3878. Anesthesiology. 2011. PMID: 21540738 Free PMC article.

3

alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.

Donello JE, Padillo EU, Webster ML, Wheeler LA, Gil DW. Donello JE, et al. Among authors: gil dw. J Pharmacol Exp Ther. 2001 Jan;296(1):216-23. J Pharmacol Exp Ther. 2001. PMID: 11123383

4

Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.

Gil DW, Cheevers CV, Kedzie KM, Manlapaz CA, Rao S, Tang E, Donello JE. Gil DW, et al. Anesthesiology. 2009 Feb;110(2):401-7. doi: 10.1097/ALN.0b013e3181943226. Anesthesiology. 2009. PMID: 19194166 Free article.

5

Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.

Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW. Kusari J, et al. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1044-51. doi: 10.1167/iovs.08-3293. Epub 2009 Aug 26. Invest Ophthalmol Vis Sci. 2010. PMID: 19710406

6

Comments on: "In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea".

Gil D. Gil D. Drugs R D. 2018 Sep;18(3):165-166. doi: 10.1007/s40268-018-0242-z. Drugs R D. 2018. PMID: 30078127 Free PMC article. No abstract available.

7

Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.

Kusari J, Padillo E, Zhou SX, Bai Y, Wang J, Song Z, Zhu M, Le YZ, Gil DW. Kusari J, et al. Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5424-31. doi: 10.1167/iovs.10-6262. Invest Ophthalmol Vis Sci. 2011. PMID: 21482645 Free PMC article.

8

Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.

Wheeler LA, Gil DW, WoldeMussie E. Wheeler LA, et al. Among authors: gil dw. Surv Ophthalmol. 2001 May;45 Suppl 3:S290-4; discussion S295-6. doi: 10.1016/s0039-6257(01)00206-5. Surv Ophthalmol. 2001. PMID: 11377451

9

Time-course of the visual Impact on presbyopes of a low dose miotic.

Xu R, Gil D, Dibas M, Rickert M, Meyer D, Perron L, Kollbaum P, Bradley A. Xu R, et al. Among authors: gil d. Ophthalmic Physiol Opt. 2021 Jan;41(1):73-83. doi: 10.1111/opo.12749. Epub 2020 Nov 4. Ophthalmic Physiol Opt. 2021. PMID: 33150654

10

Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).

Woodward DF, Krauss AH, Chen J, Liang Y, Li C, Protzman CE, Bogardus A, Chen R, Kedzie KM, Krauss HA, Gil DW, Kharlamb A, Wheeler LA, Babusis D, Welty D, Tang-Liu DD, Cherukury M, Andrews SW, Burk RM, Garst ME. Woodward DF, et al. Among authors: gil dw. J Pharmacol Exp Ther. 2003 May;305(2):772-85. doi: 10.1124/jpet.102.047837. Epub 2003 Jan 24. J Pharmacol Exp Ther. 2003. PMID: 12606640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

523 results

Search Page